Figlin RA - Search Results

1

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.

Tran HT, Liu Y, Zurita AJ, Lin Y, Baker-Neblett KL, Martin AM, Figlin RA, Hutson TE, Sternberg CN, Amado RG, Pandite LN, Heymach JV. Tran HT, et al. Among authors: figlin ra. Lancet Oncol. 2012 Aug;13(8):827-37. doi: 10.1016/S1470-2045(12)70241-3. Epub 2012 Jul 2. Lancet Oncol. 2012. PMID: 22759480

2

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

Khuri FR, Rigas JR, Figlin RA, Gralla RJ, Shin DM, Munden R, Fox N, Huyghe MR, Kean Y, Reich SD, Hong WK. Khuri FR, et al. Among authors: figlin ra. J Clin Oncol. 2001 May 15;19(10):2626-37. doi: 10.1200/JCO.2001.19.10.2626. J Clin Oncol. 2001. PMID: 11352954 Clinical Trial.

3

Prognostic factors in renal cell carcinoma.

Shuch BM, Lam JS, Belldegrun AS, Figlin RA. Shuch BM, et al. Among authors: figlin ra. Semin Oncol. 2006 Oct;33(5):563-75. doi: 10.1053/j.seminoncol.2006.06.006. Semin Oncol. 2006. PMID: 17045085 Review.

4

Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.

Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW. Halbert RJ, et al. Among authors: figlin ra. Cancer. 2006 Nov 15;107(10):2375-83. doi: 10.1002/cncr.22260. Cancer. 2006. PMID: 17048248 Free article.

5

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.

Lam JS, Breda A, Belldegrun AS, Figlin RA. Lam JS, et al. Among authors: figlin ra. J Clin Oncol. 2006 Dec 10;24(35):5565-75. doi: 10.1200/JCO.2006.08.1794. J Clin Oncol. 2006. PMID: 17158542 Review.

6

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA. Motzer RJ, et al. Among authors: figlin ra. N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Free article. Clinical Trial.

7

Renal cell cancer.

Hutson TE, Figlin RA. Hutson TE, et al. Among authors: figlin ra. Cancer J. 2007 Sep-Oct;13(5):282-6. doi: 10.1097/PPO.0b013e318156fe69. Cancer J. 2007. PMID: 17921725 Review.

8

Evolving role of novel targeted agents in renal cell carcinoma.

Hutson TE, Figlin RA. Hutson TE, et al. Among authors: figlin ra. Oncology (Williston Park). 2007 Sep;21(10):1175-80; discussion 1184, 1187, 1190. Oncology (Williston Park). 2007. PMID: 17926797 Free article. Review.

9

Dose and schedule study of panitumumab monotherapy in patients with advanced solid malignancies.

Weiner LM, Belldegrun AS, Crawford J, Tolcher AW, Lockbaum P, Arends RH, Navale L, Amado RG, Schwab G, Figlin RA. Weiner LM, et al. Among authors: figlin ra. Clin Cancer Res. 2008 Jan 15;14(2):502-8. doi: 10.1158/1078-0432.CCR-07-1509. Clin Cancer Res. 2008. PMID: 18223225 Clinical Trial.

10

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.

Jonasch E, Stadler WM, Bukowski RM, Hayes TG, Varadhachary A, Malik R, Figlin RA, Srinivas S. Jonasch E, et al. Among authors: figlin ra. Cancer. 2008 Jul 1;113(1):72-7. doi: 10.1002/cncr.23519. Cancer. 2008. PMID: 18484647 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters